Definition of infertility
Infertility is the failure to conceive after having regular unprotected sexual intercourse (every 2-3 days) for one or two years (approximately 50% of women who do not conceive in the first year are likely to do so in the second year.)
What proportion of couple will concieve naturally within 1 year and after 2 years of intercourse. What are the chances after 3 years
How can infertility be calssified
How is subfertility defined
Generally describes any form of reduced fertility that results delayed conception
What is the incidence of subfertility
What is the process (timeline) of natural conception
ALL WOMEN who intend to concieve should commence folic acid (400mcg/day)
What are some lifestye factors which confer risk of infertility
smoking, extremes of BMI, excess exercise and stress
What are the main causes of infertility
Ovulatory disorders (25% of couples), tubal damage (20% of couples), male infertility (30% of couples) and uterine and peritoneal disorders (10% of couples). Gamete or embryo defects, uterine or endometrial factors, and pelvic conditions such as endometriosis may also have significance.
* Thee is no identifiable cause of infertility in 25% of couples
What are some male causes of infertility
Can also be divided into pre-testicular, testicular and post-testicular factors of male infertility
What are some cuases of primary spermatogenic failure (any spermatogenic abnormality caused by a condition other than hypothalamic disease)
What are some genetic causes of male infertility
Klinefelter’s syndrome with karyotype 47 XXY, Kallmann syndrome, small testes, cystic fibrosis, androgen insensitivity syndrome
What is the management of male factor infertility
Describe the normal physiology of ovulation
How can anovulation be classified (THREE classifications)
Management of group 1 anovulation disorders
Advise women with group I disorders that they can improve their chances of regular ovulation, conception and uncomplicate pregnancy by:
* Increasing their body weight if they have a BMI of less than 19
* Moderating their exercise levels if they undertake high levels of exercise
Offer women with group 1 ovulation disorders pulsatile administration of GnRH or gonadotrophins with LH activity to induce ovulation
Management of group 2 anovulation disorders
Advise women with group 2 disorders who have a BMI of 30 or over to lose weight (this alone might restore fertility).
Offer one of the following treatments: clomiphene or metformin (when insulin insensitivity and obesity associated) or a combination of the above
* Clomiphene citrate is a selective oestrogen receptor modulator- stops negative feedback of oestrogen on the hypothalamus, increasing GnRH pulsatility
* Before starting clomiphene, give woman a progesterone fisrst to induce a withdrawal bleed so that you are at the start of the cycle
* Usually continued for 6 cycles
* For women taking clomiphene citrate, offer USS monitoring during at least the first cycle of treatment to ensure that they are taking doses that minimises the risk of multiple pregnancy and do not continue for longer 6 months
* Side effects of metformin include nausea, vomiting, GI disturbance
In women with PCOS who are resistant to clomiphene treatment can alternatively consider:
* Combination therapy (metformin + clomiphene)
* Letrozole (aromatase inhibitor with anti-oestrogen effects)
* GnRH OR GnRH agonist (not both concomitantly since risk of ovarian hyperstiulation)
* Ovarian drilling
Hyperprolactinaemic amenorrhoea- offer treatment with dopamine agonists such as cabergoline
What are some medications that can affect fertility
NSAIDs (inhibit ovulation), COX inhibitors, spironolactone (cause infertility and menstrual irregularities), chemotherapy, neuroleptics, contraceptives (especially PROVERA depot), recreational drug use
What are some tubal, uterine and cervical risk factors for infertility
STIs or PID, previous sterilisation, endometriosis (tubal distortion and limitation of fimbrial motility due to pelvic adhesions), cervical mucus defect, submucosal fibroids (may distort the uterine cavity and impair implantation), previous cervical or pelvic surgery
What surgical options exist for treating tubal/uterine causes of infertility
In whom is intrauterine insemination a viable treatment option
Mild endometriosis, mild male factor infertility, couples who do not have intercourse, single women, same sex couples using donor sperm, unexplained infertility
Describe the process of intrauterine insemination
Investigations for male factor infertility
Semen analysis:
* Reference ranges: Semen volume (1.5ml or more), pH (7.2 or more), Sperm concentration (15 million spermatozoa per ml or more), total (39 million spermatozoa per ejaculate or more), total motility (40%) viability (58% live), morphology (4% or more normal morphology)
* If the results of the first semen analysis is abnormal a repeat confirmatory test should be offered (should be repeated after 3 months to allow cycle of spermatozoa)
* Factors affecting semen analysis: hot baths tight underwear, smoking, alcohol, raised BMI, caffeine
* Men should abstain from ejaculation for at least 3 days and at most 7 days prior to semen analysis testing, avoid hot baths, tight underwear etc.
Vasography and testicular biopsy if indicated
Investigations for female infertility
Initial investigations in women, often performed in primary care:
* BMI (low could indicate anovulation, high may subfertility, PCOS), chlamydia screening , rubella immunity in the mother
* Hormone testing: Serum LH and FSH on day 2 to 5 of the cycle
* High LH may suggest PCOS
* Serum progesterone on day 21 of the cycle (or 7 days before the end of the cycle if not on a 28-day cycle) if they have irregular cycles
* A rise in progesterone on day 21 indicates that ovulation has occurred and that the corpus luteum has formed
* AMH
* TFTs where symptoms are suggestive
* Prolactin (if hyperprolactinaemic anovulation is suspected)- galactorrhoea or amenorrhoea
Ovarian reserve testing:
* A woman’s age should be used as an initial predictor of chances of success in natural conception or IVF
* One of the following then can be used to predict the likely response to GnRH stimulation in IVF: Total antral follicle count- Greater than 16 indicates high reserve, less than 4 indicates low reserve and likelihood of IVF success, AMH- can be measured at any time in the menstrual cycle (greater than 25 indicates high reserve, less than 5.5 indicates low reserve)-> Produced by granulosa cells and does not change in response to gonadotrophins, so it is the most successful biomarker of ovarian reserve
* FSH- greater than 8.9 IU/l for a low reserve, and less than 4 IU/l for a high reserve
Pelvic USS- to look for PCOS or structural abnormalities of the uterus
* Also allows for assessment of antral follicle count
Hysterosalpingogram- to look at the patency of fallopian tubes
* Usually only performed when there are risk factors for tubal damage (previou
* A type of scan used to assess the shape of the uterus and patency of the fallopian tubes- also of therapeutic benefit since tubal cannulation under x-ray guidance can be performed during the procedure to open up the tubes
* A small tube is inserted into the cervix, a contrast medium is injected through the tube and fills the uterine cavity and fallopian tubes. X-ray images are then taken (shows abnormalities + obstruction
* There is a risk of infection, so prophylactic antibiotics are given and screening for chlamydia and gonorrhoea are completed before the procedures ectopic, endometriosis PID)
Laparoscopy and dye test- to look at the patency of fallopian tubes, adhesions and endometriosis
* Same idea, but during laparoscopy
People undergoing IVF treatment should be offered testing for HIV, hepatitis B and hepatitis C
What intial advice should be given for infertility